Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation

Addictive Behaviors

Volumn 63, Issue , 2016, Pages 172-177

  Squeglia, Lindsay M ^a   Baker, Nathaniel L ^a   McClure, Erin A ^a   Tomko, Rachel L ^a   Adisetiyo, Vitria ^a   Gray, Kevin M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Addiction; Alcohol; Marijuana cessation; N acetyl cysteine; Randomized controlled trial

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; CANNABINOID; CANNABIS; CREATININE; PLACEBO; SCAVENGER;

ADOLESCENT; ADULT; AGE; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BINGE DRINKING; CANNABIS USE; COHORT ANALYSIS; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SELF REPORT; SUBSTANCE USE; TREATMENT DURATION; UNDERAGE DRINKING; CANNABIS ADDICTION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ACETYLCYSTEINE; ADOLESCENT; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; MARIJUANA ABUSE; TREATMENT OUTCOME; UNDERAGE DRINKING;

EID: 84981285595     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2016.08.001     Document Type: Article

References (38)

1. Bridge, J.A., Iyengar, S., Salary, C.B., Barbe, R.P., Birmaher, B., Pincus, H.A., Brent, D.A., Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA 297:15 (2007), 1683–1696.
2. Brown, S.A., Gleghorn, A., Schuckit, M.A., Myers, M.G., Mott, M.A., Conduct disorder among adolescent alcohol and drug abusers. Journal of Studies on Alcohol 57 (1996), 314–324.
3. Chaloupka, F.J., Laixuthai, A., Do youths substitute alcohol and marijuana? Some econometric evidence. Eastern Economic Journal 23:6 (1997), 253–276.
4. Copersino, M.L., Boyd, S.J., Tashkin, D.P., Huestis, M.A., Heishman, S.J., Dermand, J.C., Gorelick, D.A., Quitting among non-treatment-seeking marijuana users: Reasons and changes in other substance use. The American Journal on Addictions 15:4 (2006), 297–302.
5. Froeliger, B., McConnell, P.A., Stankeviciute, N., McClure, E.A., Kalivas, P.W., Gray, K.M., The effects of N-acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI study. Drug and Alcohol Dependence 156 (2015), 234–242.
6. Grant, J.E., Odlaug, B.L., Kim, S.W., A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. European Neuropsychopharmacology 20:11 (2010), 823–828.
7. Gray, K.M., Watson, N.L., Carpenter, M.J., Larowe, S.D., N-acetylcysteine (NAC) in young marijuana users: An open-label pilot study. The American Journal on Addictions 19:2 (2010), 187–189.
8. Gray, K.M., Carpenter, M.J., Baker, N.L., DeSantis, S.M., Kryway, E., Hartwell, K.J., Brady, K.T., A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. American Journal of Psychiatry 169:8 (2012), 805–812.
9. He, H., Tang, W., Wang, W., Crits-Christoph, P., Structural zeroes and zero-inflated models. Shanghai Archives of Psychiatry 26:4 (2014), 236–242.
10. Jacobus, J., Squeglia, L.M., Infante, M.A., Castro, N., Brumback, T., Meruelo, A.D., Tapert, S.F., Neuropsychological performance in adolescent marijuana users with co-occurring alcohol use: A three-year longitudinal study. Neuropsychology 29:6 (2015), 829–843 PMCID: 4633396.
11. Jensen, C.D., Cushing, C.C., Aylward, B.S., Craig, J.T., Sorell, D.M., Steele, R.G., Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: A meta-analytic review. Journal of Consulting and Clinical Psychology 79:4 (2011), 433–440.
12. Johnston, L.D., O'Malley, P.M., Miech, R.A., Bachman, J.G., Schulenberg, J.E., Monitoring the future national results on adolescent drug use: Overview of key findings, 2014. Ann Arbor, Michigan. 2015.
13. Kalivas, P.W., The glutamate homeostasis hypothesis of addiction. Nature Reviews Neuroscience 10:8 (2009), 561–572.
14. Kalivas, P.W., Volkow, N.D., New medications for drug addiction hiding in glutamatergic neuroplasticity. Molecular Psychiatry 16:10 (2011), 974–986.
15. Knackstedt, L.A., LaRowe, S., Mardikian, P., Malcolm, R., Upadhyaya, H., Hedden, S., Kalivas, P.W., The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biological Psychiatry 65:10 (2009), 841–845.
16. Lambert, D., Zero-inflated poisson regression, with an application to defects in manufacturing. Technometrics 34:1 (1992), 1–14.
17. LaRowe, S.D., Kalivas, P.W., Nicholas, J.S., Randall, P.K., Mardikian, P.N., Malcolm, R.J., A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. The American Journal on Addictions 22:5 (2013), 443–452.
18. Latvala, A., Rose, R.J., Pulkkinen, L., Dick, D.M., Korhonen, T., Kaprio, J., Drinking, smoking, and educational achievement: Cross-lagged associations from adolescence to adulthood. Drug and Alcohol Dependence 137 (2014), 106–113.
19. McClure, E.A., Gipson, C.D., Malcolm, R.J., Kalivas, P.W., Gray, K.M., Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs 28:2 (2014), 95–106.
20. McClure, E.A., Baker, N.L., Gray, K.M., Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents. The American Journal of Drug and Alcohol Abuse 40:4 (2014), 285–291.
21. Meier, M.H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R.S., Moffitt, T.E., Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences of the United States of America 109 (2012), E2657–E2664.
22. Miller, J.W., Naimi, T.S., Brewer, R.D., Jones, S.E., Binge drinking and associated health risk behaviors among high school students. Pediatrics 119:1 (2007), 76–85.
23. Miranda, R., Ray, L., Blanchard, A., Reynolds, E.K., Monti, P.M., Chun, T., Ramirez, J., Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: An initial randomized trial. Addiction Biology 19:5 (2014), 941–954.
24. Nguyen-Louie, T.T., Castro, N., Matt, G.E., Squeglia, L.M., Brumback, T., Tapert, S.F., Effects of emerging alcohol and marijuana use behaviors on adolescents’ neuropsychological functioning over four years. Journal of Studies on Alcohol and Drugs 76:5 (2015), 738–748.
25. Olive, M.F., Cleva, R.M., Kalivas, P.W., Malcolm, R.J., Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacology Biochemistry and Behavior 100:4 (2012), 801–810.
26. Quintanilla, M.E., Rivera-Meza, M., Berríos-Cárcamo, P., Salinas-Luypaert, C., Herrera-Marschitz, M., Israel, Y., Beyond the “First Hit”: Marked inhibition by N-acetyl cysteine of chronic ethanol intake but not of early ethanol intake. Parallel effects on ethanol-induced saccharin motivation. Alcoholism: Clinical and Experimental Research 40:5 (2016), 1044–1051.
27. Schaub, M., Gmel, G., Annaheim, B., Mueller, M., Schwappach, D., Leisure time activities that predict initiation, progression and reduction of cannabis use: A prospective, population-based panel survey. Drug and Alcohol Review 29:4 (2010), 378–384.
28. Schneider, R.J., Santos, C.F., Clarimundo, V., Dalmaz, C., Elisabetsky, E., Gomez, R., N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats. Alcohol 49:3 (2015), 259–263.
29. Sheehan, D.V., Lecrubier, Y., Harnett-Sheehan, K., Amorim, P., Janavs, J., Weiller, E., Dunbar, G., The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59:Suppl. 20 (1998), S22–S33.
30. Sheehan, D.V., Sheehan, K.H., Shytle, R.D., Janavs, J., Bannon, Y., Rogers, J.E., Wilkinson, B., Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). Journal of Clinical Psychiatry 71:3 (2010), 313–326.
31. Sobell, L.C., Sobell, M.B., Timeline Follow-back: A technique for assessing self-reported ethanol consumption. Allen, J., Litten, R.Z., (eds.) Measuring alcohol consumption: Psychosocial and biological methods, 1992, Humana Press, Totowa, NJ, 41–72.
32. Squeglia, L.M., Gray, K.M., Alcohol and drug use and the developing brain. Current Psychiatry Reports, 18(5), 2016, 46.
33. Squeglia, L.M., Spadoni, A.D., Infante, M.A., Myers, M.G., Tapert, S.F., Initiating moderate to heavy alcohol use predicts changes in neuropsychological functioning for adolescent girls and boys. Psychology of Addictive Behaviors 23:4 (2009), 715–722.
34. Tripodi, S.J., Bender, K., Litschge, C., Vaughn, M.G., Interventions for reducing adolescent alcohol abuse: A meta-analytic review. Archives of Pediatrics and Adolescent Medicine Journal 164:1 (2010), 85–91.
35. Van Schooten, F.J., Besaratinia, A., De Flora, S., D'Agostini, F., Izzotti, A., Camoirano, A., Van Zandwijk, N., Effects of oral administration of N-acetyl-L-cysteine: A multi-biomarker study in smokers. Cancer Epidemiology, Biomarkers & Prevention 11:2 (2002), 167–175.
36. Vandrey, R., Haney, M., Pharmacotherapy for cannabis dependence: How close are we?. CNS Drugs 23:7 (2009), 543–553.
37. Winters, K.C., Stinchfield, R.D., Opland, E., Weller, C., Latimer, W.W., The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers. Addiction 95 (2000), 601–612.
38. Zeger, S.L., Liang, K.Y., Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:1 (1986), 121–130.